542 related articles for article (PubMed ID: 19282153)
1. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin.
Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T
J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin.
Ding GZ; Zhao WE; Li X; Gong QL; Lu Y
Arch Dermatol Res; 2015 Apr; 307(3):281-9. PubMed ID: 25672813
[TBL] [Abstract][Full Text] [Related]
3. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
4. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
5. The involvement of Smac/DIABLO, p53, NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: Protective effects of curcumin and capsaicin.
Becatti M; Prignano F; Fiorillo C; Pescitelli L; Nassi P; Lotti T; Taddei N
Antioxid Redox Signal; 2010 Nov; 13(9):1309-21. PubMed ID: 20085492
[TBL] [Abstract][Full Text] [Related]
6. Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients.
Dell'Anna ML; Ottaviani M; Bellei B; Albanesi V; Cossarizza A; Rossi L; Picardo M
J Cell Physiol; 2010 Apr; 223(1):187-93. PubMed ID: 20049874
[TBL] [Abstract][Full Text] [Related]
7. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease.
Bessou S; Gauthier Y; Surlève-Bazeille JE; Pain C; Taïeb A
Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic features in vitiligo.
Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
[TBL] [Abstract][Full Text] [Related]
9. Perilesional vs. lesional skin changes in senile lentigo.
Cario-Andre M; Lepreux S; Pain C; Nizard C; Noblesse E; Taïeb A
J Cutan Pathol; 2004 Jul; 31(6):441-7. PubMed ID: 15186432
[TBL] [Abstract][Full Text] [Related]
10. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population.
Kim HJ; Choi CP; Uhm YK; Kim YI; Lee JW; Yoon SH; Chung JH; Lee MH
Exp Dermatol; 2007 Jul; 16(7):561-6. PubMed ID: 17576235
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival.
Becatti M; Fiorillo C; Barygina V; Cecchi C; Lotti T; Prignano F; Silvestro A; Nassi P; Taddei N
J Cell Mol Med; 2014 Mar; 18(3):514-29. PubMed ID: 24410795
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative ultrastructural study of the epidermis basal layer in the vitiligo patches and in the marginal hyperchromic and normal skin (author's transl)].
Gonçalves RP; Bechelli LM; Trad ES; Zanin LC
Ann Dermatol Venereol; 1978 Apr; 105(4):395-400. PubMed ID: 686613
[TBL] [Abstract][Full Text] [Related]
13. Vitiligo - The story from within: A transmission electron microscopic study before and after narrow-band ultraviolet B.
Fawzy MM; El Maadawi ZM; Hegazy RA; El Fatah NS
Ultrastruct Pathol; 2016; 40(5):265-75. PubMed ID: 27594347
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin?
Prignano F; Betts CM; Lotti T
J Electron Microsc (Tokyo); 2008 Jan; 57(1):25-31. PubMed ID: 18174263
[TBL] [Abstract][Full Text] [Related]
15. The perilesional skin in vitiligo: a colorimetric in vivo study of 25 patients.
Brazzelli V; Muzio F; Antoninetti M; Villani S; Donadini F; Altomare A; Borroni G
Photodermatol Photoimmunol Photomed; 2008 Dec; 24(6):314-7. PubMed ID: 19000189
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
Rojas-Urdaneta JE; Poleo-Romero AG
Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
[TBL] [Abstract][Full Text] [Related]
17. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo.
Norris A; Todd C; Graham A; Quinn AG; Thody AJ
Br J Dermatol; 1996 Feb; 134(2):299-306. PubMed ID: 8746346
[TBL] [Abstract][Full Text] [Related]
18. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.
Moretti S; Spallanzani A; Amato L; Hautmann G; Gallerani I; Fabiani M; Fabbri P
Pigment Cell Res; 2002 Apr; 15(2):87-92. PubMed ID: 11936274
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural findings in progressive macular hypomelanosis indicate decreased melanin production.
Relyveld GN; Dingemans KP; Menke HE; Bos JD; Westerhof W
J Eur Acad Dermatol Venereol; 2008 May; 22(5):568-74. PubMed ID: 18266692
[TBL] [Abstract][Full Text] [Related]
20. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
